FDA
approval
· 2021-01-22
FDA Approved: CLONAZEPAM — Supplemental Application (Par Health USA, LLC)
Summary
The FDA approved a supplemental application for clonazepam from Par Health USA, LLC under an ANDA, signaling approval of a supplemental filing for a generic clo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLONAZEPAM (CLONAZEPAM)